The PPAR<i>γ</i>Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial EffectsGalina S. Bogatkevich, Richard M. Silver|Pulmonary Medicine|2011Cited by 20